Completed
It is increasingly recognized that many patients, while fulfilling traditional criteria for response or remission of depression, continue to have subjective complaints and have difficulties returning to their previous level of function (e.g., returning to work). Increasing clinical and epidemiologic evidence suggests that cognitive dysfunction is an underestimated dimension of depression. The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on February 24, 2015, bringing together key stakeholders, to explore ways of speeding improvement of the discovery, development and regulatory path for new treatments addressing this aspect of depression.
Featured publication
Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary
Proceedings
·2015
Major depressive disorder (MDD) is recognized worldwide as a major cause of disability, morbidity, and mortality. According to the World Health Organization, unipolar depressive disorders affect more than 150 million people around the world and represent the leading cause of years lost due to disabi...
View details